Aerosolized Amikacin as Adjunctive Therapy of Ventilator-associated Pneumonia Caused by Multidrug-resistant Gram-negative Bacteria: A Single-center Randomized Controlled Trial

Aerosolized Amikacin as Adjunctive Therapy of Ventilator-associated Pneumonia Caused by Multidrug-resistant Gram-negative Bacteria: A Single-center Randomized Controlled Trial

Background: Aerosolized amikacin (AA) is a current option for the management of ventilator-associated pneumonia (VAP) caused by multidrug-resistant Gram-negative bacteria (MDR-GNB), as it is reported that AA could increase the alveolar level of the drug without increasing systemic toxicity. This stu...

Full description

Bibliographic Details
Main Authors: Chang Liu, Yu-Ting Zhang, Zhi-Yong Peng, Qing Zhou, Bo Hu, Hui Zhou, Jian-Guo Li
Format: Article
Language:English
Published: Wolters Kluwer 2017-01-01
Series:Chinese Medical Journal
Subjects:
Aerosol Drug Therapy; Amikacin; Gram-negative Bacteria; Multidrug Resistance; Pneumonia
Ventilator-associated
Online Access:http://www.cmj.org/article.asp?issn=0366-6999;year=2017;volume=130;issue=10;spage=1196;epage=1201;aulast=Liu

Internet

http://www.cmj.org/article.asp?issn=0366-6999;year=2017;volume=130;issue=10;spage=1196;epage=1201;aulast=Liu

Similar Items